What are your thoughts on the CEO not presenting yesterday at
a West Coast Confab, and the newly minted CFO doing said?
Do you sense the CEO is out?
With the lack of any PR's on the ongoing trials, do you think ACTc
is in the midst of some type of due diligence by a Big Pharma Co
either for JV reasons, or even a buyout?
The last time there was anything PR's related to the ongoing trials
was July 17, almost 6 months ago.
Your thoughts would be appreciated.